Approval of unaudited financial results (Standalone and Consolidated) of the Company for the Half-year ended September 2025, and take note of the Limited Review Report of the Statutory Auditors.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.9 pts less than Nifty Microcap 250 and 4.9 pts less than its Beverages peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Valencia Nutrition reported a strong turnaround in H1 FY26 (Apr-Sep 2025). Standalone revenue from operations more than doubled to ₹361.65 lakhs (vs ₹154.55 lakhs in H1 FY25), and the company swung from a loss of ₹121.81 lakhs to a profit of ₹59.30 lakhs (EPS of ₹0.35). On a consolidated basis, total revenue was ₹404.10 lakhs with a profit of ₹65.96 lakhs, aided by subsidiary Valencia Beverages & SuperWater contributing a small profit. However, operating cash flow was sharply negative at ₹(502.88) lakhs (consolidated), and cash balances dropped from ₹789.78 lakhs to ₹20.43 lakhs. Long-term borrowings surged from ₹148.67 lakhs to ₹1,779.14 lakhs, largely from related-party unsecured loans, used for setting up a manufacturing unit, new product launches, and the Valencia Online Platform.
Positive turnaround in profitability and revenue growth is encouraging for shareholders, but the steep rise in debt, near-empty cash balance, and large negative operating cash flow raise concerns about funding and liquidity. Short-term sentiment may improve on the profit comeback, but investors should watch how the manufacturing and online platform investments translate into sustained cash generation.